Metabolism/Immunity Dual‐Regulation Thermogels Potentiating Immunotherapy of Glioblastoma Through Lactate‐Excretion Inhibition and PD‐1/PD‐L1 Blockade

T Li, D Xu, Z Ruan, J Zhou, W Sun, B Rao… - Advanced …, 2024 - Wiley Online Library
Intrinsic immunosuppressive tumor microenvironment (ITM) and insufficient tumor infiltration
of T cells severely impede the progress of glioblastoma (GBM) immunotherapy. In this study …

Metabolism/Immunity Dual-Regulation Thermogels Potentiating Immunotherapy of Glioblastoma Through Lactate-Excretion Inhibition and PD-1/PD-L1 Blockade.

T Li, D Xu, Z Ruan, J Zhou, W Sun, B Rao… - Advanced Science …, 2024 - europepmc.org
Intrinsic immunosuppressive tumor microenvironment (ITM) and insufficient tumor infiltration
of T cells severely impede the progress of glioblastoma (GBM) immunotherapy. In this study …

Metabolism/Immunity Dual-Regulation Thermogels Potentiating Immunotherapy of Glioblastoma Through Lactate-Excretion Inhibition and PD-1/PD-L1 Blockade

T Li, D Xu, Z Ruan, J Zhou, W Sun… - Advanced science …, 2024 - pubmed.ncbi.nlm.nih.gov
Intrinsic immunosuppressive tumor microenvironment (ITM) and insufficient tumor infiltration
of T cells severely impede the progress of glioblastoma (GBM) immunotherapy. In this study …

[HTML][HTML] Metabolism/Immunity Dual‐Regulation Thermogels Potentiating Immunotherapy of Glioblastoma Through Lactate‐Excretion Inhibition and PD‐1/PD‐L1 …

T Li, D Xu, Z Ruan, J Zhou, W Sun, B Rao… - Advanced Science, 2024 - ncbi.nlm.nih.gov
Intrinsic immunosuppressive tumor microenvironment (ITM) and insufficient tumor infiltration
of T cells severely impede the progress of glioblastoma (GBM) immunotherapy. In this study …

Metabolism/Immunity Dual-Regulation Thermogels Potentiating Immunotherapy of Glioblastoma Through Lactate-Excretion Inhibition and PD-1/PD-L1 Blockade.

T Li, D Xu, Z Ruan, J Zhou, W Sun, B Rao… - Advanced Science …, 2024 - europepmc.org
Intrinsic immunosuppressive tumor microenvironment (ITM) and insufficient tumor infiltration
of T cells severely impede the progress of glioblastoma (GBM) immunotherapy. In this study …